Elevating Standards in Radiopharmaceutical Therapy with APEx
Posted: October 30, 2025When Miami Cancer Institute (MCI) became one of the first practices in the United States to achieve the new radiopharmaceutical therapy (RPT) designation through ASTRO’s APEx – Accreditation Program for Excellence®, it was more than a milestone — it was a statement of where radiation oncology and medical physics are heading.
ASTRO’s Efforts with Promoting Radiopharmaceutical Therapy in Radiation Oncology
Posted: November 19, 2024ASTRO has been actively developing resources for radiopharmaceutical therapies and continues to advocate for radiation oncology in many ways. Here is a roundup of efforts over the past several years.
How to Obtain Authorized User Status
Posted: August 9, 2023In 2022, the American Board of Radiology announced that it was terminating the Nuclear Regulatory Commission recognition of all ABR certification processes after December 31, 2023. This change is important for radiation oncologists that want to begin offering radiopharmaceuticals but have not previously offered treatments regulated by the NRC, such as brachytherapy or radiopharmaceutical therapy.
ASTRO Engages RPT Stakeholders
Posted: June 13, 2023Learn more about ASTRO's recent activities regarding radiopharmaceutical therapies from John Buatti, MD, FASTRO, vice-chair of the ASTRO Science Council and chair of the RPT Work Group.
How to Become a Licensee or an Authorized User for Radiopharmaceuticals
Posted: April 26, 2022Is your practice interested in becoming licensed to use radiopharmaceuticals? Or, are you interested in becoming an authorized user to administer radiopharmaceuticals? With new radiopharmaceuticals gaining approval from the U.S Food and Drug Administration and more in the pipeline, now is a good time to understand some practical steps to take.
